Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where C. De Jonghe is active.

Publication


Featured researches published by C. De Jonghe.


Journal of Neurochemistry | 2001

Phosphatidylinositol 3-kinase activity is required for the expression of glial fibrillary acidic protein upon cAMP-dependent induction of differentiation in rat C6 glioma

Dirk Roymans; Kris Vissenberg; C. De Jonghe; Bert Grobben; Patrik Claes; Jean-Pierre Verbelen; C. Van Broeckhoven; Herman Slegers

Glial fibrillary acidic protein (GFAP) is an intermediate filament (IF) protein expressed upon maturation of astrocytes and upregulated during reactive astrogliosis. Its expression is modulated by several growth factors and hormones. Although an upregulation of intracellular cAMP is required for the induction of GFAP expression in astrocytes, little information is available on other downstream factors of the signal transduction pathways involved in the regulation of its expression. In this communication, we identified phosphatidylinositol 3‐kinase (PI 3‐K) as a necessary enzyme for GFAP expression in rat C6 glioma cells. Use of the specific PI 3‐K inhibitors wortmannin and LY294002 and transfection of C6 cells with a dominant negative PI 3‐K construct, resulting in a decrease of the enzymatic activity of PI 3‐K, inhibited the cAMP‐dependent expression of GFAP. Furthermore, confocal laser scanning microscopy demonstrated that inhibition of the PI 3‐K activity by LY294002 or wortmannin concomitant with induction of differentiation changes the cellular distribution leading to a pericentrosomal localization of GFAP and an altered cell shape lacking process formation. We conclude that the expression and cellular distribution of GFAP is mediated through a PI 3‐K‐dependent mechanism.


Human Molecular Genetics | 1995

Molecular genetic analysis of familial early-onset Alzheimer's disease linked to chromosome 14q24.3

Marc Cruts; Hubert Backhovens; Sheng-Yue Wang; G. Van Gassen; Jessie Theuns; C. De Jonghe; Anita Wehnert; J. De Voecht; G. De Winter; P. Cras; Marc Bruyland; Nicole A. Datson; Jean Weissenbach; J.T. den Dunnen; J.-J. Martin; Lydia Hendriks; C. Van Broeckhoven


Brain | 2001

Cerebral amyloid angiopathy is a pathogenic lesion in Alzheimer's disease due to a novel presenilin 1 mutation

Bart Dermaut; Samir Kumar-Singh; C. De Jonghe; M Cruts; A. Löfgren; Ursula Lübke; Patrick Cras; René Dom; P.P. De Deyn; J. J. Martin; C. Van Broeckhoven


Human Molecular Genetics | 1999

Aberrant Splicing in the Presenilin-1 Intron 4 Mutation Causes Presenile Alzheimer's Disease by Increased Aβ42 Secretion

C. De Jonghe; M Cruts; Ekaterina Rogaeva; C Tysoe; Amanda Singleton; Hugo Vanderstichele; Wendy S. Meschino; Bart Dermaut; Inge Vanderhoeven; Hubert Backhovens; Eugeen Vanmechelen; Christopher Morris; John Hardy; David C. Rubinsztein; P. St George-Hyslop; C. Van Broeckhoven


Experimental Cell Research | 2000

Nucleoside Diphosphate Kinase β (Nm23-R1/NDPKβ) Is Associated with Intermediate Filaments and Becomes Upregulated upon cAMP-Induced Differentiation of Rat C6 Glioma

Dirk Roymans; Roel Willems; Kris Vissenberg; C. De Jonghe; Bert Grobben; Patrik Claes; I Lascu; D. R. Van Bockstaele; Jean-Pierre Verbelen; C. Van Broeckhoven; Herman Slegers


Molecular Medicine | 2000

Evidence that the beta-catenin nuclear translocation assay allows for measuring presenilin 1 dysfunction.

G. Van Gassen; C. De Jonghe; M. Nishimura; Gang Yu; Sofie Kuhn; P. St George-Hyslop; C. Van Broeckhoven


Proceedings of the 6th International Conference on Alzheimer's Disease and Related Disorders / Iqbal, K. [edit.] | 1999

A presenilin-1 truncating mutation causing Alzheimer's disease

C. De Jonghe; Carolyn Tysoe; Marc Cruts; Inge Vanderhoeven; Hugo Vanderstichele; Eugeen Vanmechelen; C. Van Broeckhoven; David C. Rubinsztein; Lydia Hendriks


American Journal of Human Genetics | 1999

Aberrant splicing in the presenilin-1 intron 4 mutation causes presenile Alzheimers disease by increased a beta 42 secretion

M Cruts; C. De Jonghe; E. Rogaeva; Carolyn Tysoe; Amanda Singleton; Hugo Vanderstichele; Wendy S. Meschino; Bart Dermaut; Inge Vanderhoeven; Hubert Backhovens; Eugeen Vanmechelen; Christopher Morris; J Hardy; David C. Rubinsztein; P. St George-Hyslop; C. Van Broeckhoven


Alzheimer's disease and related disorders : etiology, pathogenesis and therapeutics | 1999

Glu318gly in presenilin-1 is a neutral mutation in relation to dementia: the Rotterdam study

Bart Dermaut; M Cruts; Arjen J. C. Slooter; S Van Gestel; C. De Jonghe; Hubert Backhovens; Hugo Vanderstichele; Eugeen Vanmechelen; M.M.B. Breteler; Albert Hofman; Lydia Hendriks; C. M. van Duijn; C. Van Broeckhoven


Neurobiology of Aging | 1996

445 Expression of wild-type and mutant presenilin-1 cDNA in non-neuronal and neuronal cells

Lydia Hendriks; C. De Jonghe; W. Van Ael; Ursula Lübke; Patrick Cras; Jean-Jaques Martin; C. Van Broeckhoven

Collaboration


Dive into the C. De Jonghe's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M Cruts

University of Antwerp

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge